APG Asset Management US’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,894
Closed -$4.19M 169
2025
Q3
$4.19M Hold
7,894
0.03% 82
2025
Q2
$3.33M Hold
7,894
0.02% 82
2025
Q1
$3.81M Hold
7,894
0.03% 78
2024
Q4
$4.11M Buy
+7,894
New +$4.34M 0.03% 74
2024
Q3
Sell
-140,194
Closed -$75.9M 186
2024
Q2
$75.9M Sell
140,194
-3,832
-3% -$2.2M 0.43% 37
2024
Q1
$83.2M Buy
144,026
+51,549
+56% +$28.9M 0.48% 36
2023
Q4
$49.1M Buy
+92,477
New +$44.8M 0.3% 38

Other funds holding TMO

APG Asset Management US's TMO Position: Q4 2025 in Review

APG Asset Management US sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 7,894 shares — an estimated $4.19M sold.

APG Asset Management US first reported a position in TMO in Q4 2023 and held it in 7 quarters. The position peaked at $83.2M in Q1 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • APG Asset Management US reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 7,894 Thermo Fisher Scientific shares in Q4 2025, an estimated $4.19M.
  • APG Asset Management US first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 7 quarters.
  • APG Asset Management US's Thermo Fisher Scientific position peaked at $83.2M in Q1 2024.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.